“…The prevalence in these countries is similar to that reported in South European countries which is approximately 3 to 24 % in VTE patients and 1 to 12 % in the general population [11]. Previous studies have reported the absence of this mutation among healthy controls in Asian populations in China, Japan, Korea, Mongolia, Taiwan, Indonesia, Burma, Cambodia, Thailand, Taiwan, Vietnam, Hong Kong, Pakistan and Bangladesh [11,12,[15][16][17][18][19][21][22][23][24][25], while in India it was reported to be between 0 to 0.6 % [11,19,22,[25][26][27][28][29]. Among the VTE patients in China, Korea, and Taiwan, the prevalence of the mutation carriers was 0 % [11,12,[15][16][17][19][20][21][22][23][24].…”